The DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.
Controversies in translational research: drug self-administration.
Open accessAbstract
Rationale Laboratory animal and human models of drug self-administration are used to evaluate potential pharmacotherapies for drug abuse, yet the utility of these models in predicting clinically useful medications is variable.Objective The objective of this study was to track how antagonist, agonist, and partial agonist medication approaches influence heroin and cocaine self-administration by rodents, non-human primates, and humans and to compare these results to clinical outcomes.Results Across species, heroin self-administration was decreased by all three medication approaches, paralleling their demonstrated clinical utility. The heroin data emphasize the importance of assessing a medication's abuse liability preclinically to predict medication abuse and compliance and of considering subject characteristics (e.g., opioid dependence) when interpreting medication effects. For cocaine, the effects of ecopipam, modafinil, and aripiprazole were consistent in the laboratory and clinic, provided that the medications were administered repeatedly before self-administration sessions. Modafinil attenuated cocaine's reinforcing effects in the human laboratory and improved treatment outcome, while ecopipam and aripiprazole increased the reinforcing effects of cocaine and do not appear promising in the clinic.Conclusions The self-administration model has reliably identified medications to treat opioid dependence, and the recent data with modafinil suggest that the human laboratory model also identifies medications to treat cocaine dependence. There have been numerous false positives when subjective effects are the primary outcome measure, but not when self-administration is the outcome. Factors relevant to the predictive validity of self-administration procedures include medication maintenance and the concurrent assessment of a range of behaviors to determine abuse liability and the specificity of effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been noted that acute compared with chronic antagonism of the dopamine receptor elicits opposite effects on cocaine reinforcement in both human and non-human subjects 76.”
From Psychosocial and pharmacological interventions for the treatment of cannabis use disorder (2018) · cites this paper as [76]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,756
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Richardson, N. R., & Roberts, D. C. S. (1996) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(95)00153-0 · Cited by 1,373
Dole, V. P. (1965) · JAMA · doi:10.1001/jama.1965.03090080008002 · Cited by 1,240
Self-administration of psychoactive substances by the monkey
Deneau, G. A., Yanagita, T., & Seevers, M. H. (1969) · Psychopharmacology · doi:10.1007/bf00405254 · Cited by 808
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782
Methods of Assessing the Reinforcing Properties of Abused Drugs
Bozarth, M. A. (1987) · Springer eBooks · doi:10.1007/978-1-4612-4812-5 · Cited by 693
Experimental Morphine Addiction: Method for Automatic Intravenous Injections in Unrestrained Rats
Weeks, J. R. (1962) · Science · doi:10.1126/science.138.3537.143 · Cited by 658
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems
Ettenberg, A., Pettit, H. O., Bloom, F. E., & Koob, G. F. (1982) · Psychopharmacology · doi:10.1007/bf00428151 · Cited by 563
Research works printed but not linked: 2
- Emmett-Oglesby M, Mathis D (1988) Chronic administration of SCH 23390 produces sensitization to the discriminative stimulus properties of cocaine. In: Harris LS (ed) Problems of drug dependence. Proceedings of the 50th Annual Scientific Meeting, The College on Problems of Drug Dependence. United States Department of Health and Human Services, Rockville, MD, p 367
- Jasinksi DR, Pervnick JS, Griffith JD (1978) Human pharmacology and abuse potential of the analgesic buprenorphine. Arch Gen Psychiatry 35:601–616
Cited by
Sorted by citations
Items 101–200 of 268
Townsend, E. A., Bremer, P. T., Faunce, K. E., Negus, S. S., Jaster, A. M., Robinson, H. L., Janda, K. D., & Banks, M. L. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00064 · Cited by 33
Thomsen, M., Fulton, B. S., & Caine, S. B. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3256-9 · Cited by 33
Medications Development for Opioid AbusePreprint
Negus, S. S., & Banks, M. L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012104 · Cited by 34
Stoops, W. W., Pike, E., Hays, L. R., Glaser, P. E. A., & Rush, C. R. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.11.018 · Cited by 32
Rivastigmine reduces “likely to use methamphetamine” in methamphetamine-dependent volunteers
Garza, R. D. L., Newton, T. F., Haile, C. N., Yoon, J. H., Nerumalla, C. S., Mahoney, J. J., & Aziziyeh, A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.014 · Cited by 32
Johnson, A. R., Banks, M. L., Blough, B. E., Lile, J. A., Nicholson, K. L., & Negus, S. S. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.05.021 · Cited by 32
Utility of Nonhuman Primates in Substance Use Disorders Research
Banks, M. L., Czoty, P. W., & Negus, S. S. (2017) · ILAR Journal · doi:10.1093/ilar/ilx014 · Cited by 36
Vosburg, S. K., Haney, M., Rubin, E., & Foltin, R. W. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.02.015 · Cited by 31
Self-citationAnimal models for addiction medicine
Nader, M. A. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.07.012 · Cited by 34
Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers
Haney, M., Cooper, Z. D., Bedi, G., Herrmann, E., Comer, S. D., Reed, S. C., Foltin, R. W., & Levin, F. R. (2019) · Addiction Biology · doi:10.1111/adb.12621 · Cited by 31
Self-citationBergman, J. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0014398 · Cited by 31
A review of nonhuman primate models of early life stress and adolescent drug abuse
Wakeford, A. G. P., Morin, E. L., Bramlett, S. N., Howell, L. L., & Sánchez, M. M. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.09.005 · Cited by 30
Influence of acute bupropion pre‐treatment on the effects of intranasal cocaine
Stoops, W. W., Lile, J. A., Glaser, P. E. A., Hays, L. R., & Rush, C. R. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03766.x · Cited by 28
Banks, M., Blough, B., & Negus, S. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.193 · Cited by 25
Lile, J. A., Stoops, W. W., Glaser, P. E. A., Hays, L. R., & Rush, C. R. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110385597 · Cited by 27
Activin A is increased in the nucleus accumbens following a cocaine binge
Wang, Z., Martin, J. A., Gancarz, A. M., Adank, D. N., Sim, F. J., & Dietz, D. (2017) · Scientific Reports · doi:10.1038/srep43658 · Cited by 27
Challenges for translational psychopharmacology research—some basic principles
Miczek, K. A., & de Wit, H. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1198-4 · Cited by 29
Current approaches and issues in non-clinical evaluation of abuse and dependence
Moser, P. C., Wolinsky, T. D., Castagné, V., & Duxon, M. S. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.09.004 · Cited by 27
Moline, M. L., Asakura, S., Beuckmann, C. T., Landry, I. S., Setnik, B., Ashworth, J., & Henningfield, J. E. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06320-y · Cited by 25
Banks, M. L., & Blough, B. E. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.63 · Cited by 25
Garza, R. D. L., Verrico, C. D., Newton, T. F., Mahoney, J. J., & Thompson-Lake, D. G. Y. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv098 · Cited by 25
Thomsen, M., Barrett, A. C., Butler, P., Negus, S. S., & Caine, S. B. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.241141 · Cited by 25
Pharmacotherapeutic management of co-morbid alcohol and opioid use
Hood, L. E., Leyrer‐Jackson, J. M., & Olive, M. F. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1732349 · Cited by 25
Medications Development for Treatment of Opioid Use DisorderPreprint
Townsend, E. A., Negus, S. S., & Banks, M. L. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039263 · Cited by 25
Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans
Stoops, W. W., Lile, J. A., Glaser, P. E. A., Hays, L. R., & Rush, C. R. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.06.055 · Cited by 24
Negus, S. S., & Banks, M. L. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173264 · Cited by 24
Establishment of multi-stage intravenous self-administration paradigms in mice
Slosky, L. M., Pires, A., Bai, Y., Clark, N. B., Hauser, E. R., Gross, J., Porkka, F., Zhou, Y., Chen, X., Pogorelov, V. M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-24740-2 · Cited by 25
An fMRI-Based Neural Signature of Decisions to Smoke Cannabis
Bedi, G., Lindquist, M. A., & Haney, M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.135 · Cited by 24
Self-citationTownsend, E. A., & Banks, M. L. (2020) · CNS Drugs · doi:10.1007/s40263-020-00722-8 · Cited by 24
Negus, S. S., & Banks, M. L. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00815-4 · Cited by 24
Muscarinic receptor M 4 positive allosteric modulators attenuate central effects of cocaine
Dall, C., Weikop, P., Dencker, D., Molander, A., Wörtwein, G., Conn, P. J., Fink‐Jensen, A., & Thomsen, M. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.03.014 · Cited by 23
Johnson, B. A., Roache, J. D., Ait‐Daoud, N., Gunderson, E. W., Haughey, H. M., Wang, X., & Liu, L. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00499.x · Cited by 23
John, W. S., Newman, A. H., & Nader, M. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.024 · Cited by 22
Flynn, S. M., Epperly, P. M., Davenport, A. T., Cami‐Kobeci, G., Husbands, S. M., Ko, M., & Czoty, P. W. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0390-z · Cited by 22
Garza, R. D. L., Bubar, M. J., Carbone, C. L., Moeller, F. G., Newton, T. F., Anastasio, N. C., Harper, T. A., Ware, D. L., Fuller, M. A., Holstein, G. J., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.01.009 · Cited by 22
Psychosocial and Pharmacological Interventions for the Treatment of Cannabis Use Disorder
Sabioni, P., & Foll, B. L. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17202 · Cited by 22
Vollmer, K. M., Doncheck, E. M., Grant, R. I., Winston, K. T., Romanova, E. V., Bowen, C. W., Siegler, P. N., Green, L. M., Bobadilla, A., Trujillo‐Pisanty, I., et al. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.744715 · Cited by 22
Borodovsky, J. T. (2022) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000581 · Cited by 27
Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals
Grasing, K., Mathur, D., Newton, T. F., & DeSouza, C. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.09.010 · Cited by 21
Stoops, W. W., Strickland, J. C., Alcorn, J. L., Hays, L. R., Rayapati, A. O., Lile, J. A., & Rush, C. R. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05227-x · Cited by 21
Lile, J. A., Stoops, W. W., Hays, L. R., & Rush, C. R. (2008) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990802308262 · Cited by 21
Negus, S. S., & Banks, M. L. (2011) · doi:10.1002/9781118023150.ch11 · Cited by 21
Wetzel, H. N., Tsibulsky, V. L., & Norman, A. B. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.09.024 · Cited by 20
New dimensions in human laboratory models of addiction
Koob, G. F. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00127.x · Cited by 20
The interplay between brain 5-hydroxytryptamine levels and cocaine addiction
Nonkes, L. J. P., van Bussel, I. P. G., Verheij, M. M. M., & Homberg, J. R. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32834d6260 · Cited by 19
Methamphetamine Self-Administration in Humans During d-Amphetamine Maintenance
Pike, E., Stoops, W. W., Hays, L. R., Glaser, P. E. A., & Rush, C. R. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000207 · Cited by 19
Marks, K. R., Lile, J. A., Stoops, W. W., Glaser, P. E. A., Hays, L. R., & Rush, C. R. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000488 · Cited by 19
Cross-reinstatement of mitragynine and morphine place preference in rats
Japarin, R. A., Yusoff, N. H. M., Hassan, Z., Müller, C. P., & Harun, N. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113021 · Cited by 20
Mu, L., Liu, X., Yu, H., Hu, M.-M., Friedman, V., Kelly, T. J., Zhao, L., & Liu, Q.-S. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108830 · Cited by 19
Advances in Animal Models of Drug Addiction
Heidbreder, C. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_107 · Cited by 20
Anatabine significantly decreases nicotine self-administration.
Mello, N. K., Fivel, P. A., Kohut, S. J., & Caine, S. B. (2014) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0035409 · Cited by 19
Mini review: Potential therapeutic values of mitragynine as an opioid substitution therapy
Harun, N., Kamaruzaman, N. A., Sofian, Z. M., & Hassan, Z. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136500 · Cited by 16
Sex differences in the subjective and reinforcing effects of smoked cannabis
Lake, S., Haney, M., & Cooper, Z. D. (2023) · Addiction Biology · doi:10.1111/adb.13301 · Cited by 17
Self-citationChao, T. W.-C., Radoncic, V., Hien, D. A., Bedi, G., & Haney, M. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.11.021 · Cited by 19
Self-citationPotretzke, S., Zhang, Y., Li, J., Fecteau, K. M., Erikson, D. W., Hibert, M., & Ryabinin, A. E. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01490-3 · Cited by 17
5HT‐2C agonist lorcaserin decreases cannabis self‐administration in daily cannabis smokers
Arout, C. A., Cooper, Z. D., Collins, S. L., Foltin, R. W., Comer, S. D., LEVIN, F. R., & Haney, M. (2021) · Addiction Biology · doi:10.1111/adb.12993 · Cited by 16
Self-citationFoltin, R. W., Haney, M., Bedi, G., & Evans, S. M. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.08.009 · Cited by 16
Self-citationLi, C., & Frantz, K. J. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.06.003 · Cited by 15
Banks, M. L. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13276 · Cited by 16
Townsend, E. A. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05749-9 · Cited by 15
Hutsell, B. A., Negus, S. S., & Banks, M. L. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.11.003 · Cited by 15
Kim, T., Hinton, D. J., Johng, S., Wang, J. B., & Choi, D. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.028 · Cited by 15
Attenuation of cocaine self-administration by chronic oral phendimetrazine in rhesus monkeys
Czoty, P., Blough, B., Fennell, T., Snyder, R. W., & Nader, M. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.002 · Cited by 11
Butler, K., & Foll, B. L. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1767581 · Cited by 14
Schwienteck, K. L., & Banks, M. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.08.022 · Cited by 13
Relationship between oral D-amphetamine self-administration and ratings of subjective effects
Bolin, B. L., Reynolds, A. R., Stoops, W. W., & Rush, C. R. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283645047 · Cited by 13
Bergeria, C. L., Heil, S. H., Davis, D. R., Streck, J. M., Sigmon, S. C., Bunn, J. Y., Tidey, J. W., Arger, C. A., Reed, D. D., Gallagher, T. J., et al. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.01.004 · Cited by 13
Cippitelli, A., Martinez, M., Zribi, G., Cami‐Kobeci, G., Husbands, S. M., & Toll, L. (2021) · SSRN Electronic Journal · doi:10.1016/j.neuropharm.2022.109045 · Cited by 13
Acuff, S. F., Oddo, L. E., Johansen, A. N., & Strickland, J. C. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173802 · Cited by 11
Negus, S. S., Mello, N. K., Kimmel, H. L., Howell, L., & Carroll, F. I. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.08.002 · Cited by 12
Babinská, Z., Kučerová, J., Amchová, P., Merhautová, J., Dušek, L., & Šulcová, A. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.09.035 · Cited by 12
Modeling chronic olanzapine exposure using osmotic minipumps: Pharmacological limitations
Remington, G. J., Mann, S. W., McCormick, P. N., Nóbrega, J. N., Hahn, M., & Natesan, S. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.07.019 · Cited by 11
Czoty, P. W., & Nader, M. A. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.266007 · Cited by 11
Newton, T. F., Garza, R. D. L., & Grasing, K. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.11.011 · Cited by 11
Rush, C. R., Stoops, W. W., Lile, J. A., Glaser, P. E. A., & Hays, L. R. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.024 · Cited by 11
Safety and tolerability of intranasal cocaine during phendimetrazine maintenance
Stoops, W. W., Strickland, J., Hays, L., Rayapati, A., Lile, J., & Rush, C. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4260-7 · Cited by 9
Reynolds, A. R., Strickland, J. C., Stoops, W. W., Lile, J. A., & Rush, C. R. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.08.038 · Cited by 11
Acute buspirone dosing enhances abuse-related subjective effects of oral methamphetamine
Pike, E., Stoops, W. W., & Rush, C. R. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.09.009 · Cited by 10
Xu, H., Das, S., Sturgill, M. G., Hodgkinson, C. A., Yuan, Q., Goldman, D. A., & Grasing, K. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4640-7 · Cited by 10
Murray, C. H., Haney, M., Foltin, R. W., Manubay, J. M., Bedi, G., & Cooper, Z. D. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109757 · Cited by 9
Self-citationRegnier, S. D., Lile, J. A., Rush, C. R., & Stoops, W. W. (2022) · Journal of the Experimental Analysis of Behavior · doi:10.1002/jeab.744 · Cited by 10
The Persistent Challenge of Developing Addiction PharmacotherapiesPreprint
Swinford-Jackson, S. E., O’Brien, C. P., Kenny, P. J., Vanderschuren, L. J. M. J., Unterwald, E. M., & Pierce, R. C. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a040311 · Cited by 10
Panayi, M. C., Shetty, S., Porod, M., Bahena, L., Xi, Z., Newman, A. H., & Schoenbaum, G. M. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01858-7 · Cited by 10
Computer-controlled drug doses for IV drug self-administration.
Fivel, P. A. (2011) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0023037 · Cited by 8
Naltrexone-bupropion combinations do not affect cocaine self-administration in humans
Regnier, S. D., Stoops, W. W., Lile, J. A., Alcorn, J. L., Bolin, B. L., Reynolds, A. R., Hays, L. R., Rayapati, A. O., & Rush, C. R. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173526 · Cited by 8
Human laboratory models of reward in substance use disorder
Johansen, A. N., Acuff, S. F., & Strickland, J. C. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173803 · Cited by 8
Oliva, A. B., Reed, S. C., Brooks, D. J., LEVIN, F. R., & Evans, S. M. (2022) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2022.2114004 · Cited by 8
Upregulation of P2X2 and P2X3 receptors in rats with hyperalgesia induced by heroin withdrawal
Leng, C., Chen, L., Gong, X., Ma, B., Gan, W., Si, Y., Xiao, H., & Li, C. (2018) · NeuroReport · doi:10.1097/wnr.0000000000001018 · Cited by 8
Influence of experimental history on nicotine self-administration in squirrel monkeys
Desai, R. I., Sullivan, K. A., Kohut, S. J., & Bergman, J. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4274-1 · Cited by 6
Lile, J. A., Alcorn, J. L., Hays, L. R., Kelly, T. H., Stoops, W. W., Wesley, M. J., & Westgate, P. M. (2021) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000464 · Cited by 7
Wakeford, A. G. P., Morin, E. L., Bramlett, S. N., Howell, B., McCormack, K. M., Meyer, J. S., Nader, M. A., Sánchez, M. M., & Howell, L. L. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05254-8 · Cited by 7
Roux, P., Tindall, C., Fugon, L., Murray, J., Vosburg, S. K., Saccone, P. A., Sullivan, M. A., Manubay, J. M., Cooper, Z. D., Jones, J. D., et al. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03664.x · Cited by 7
Mirtazapine reduces hypothetical methamphetamine demand in humans
Rush, C. R., Santos, G., McMahan, V., Fraser, A., Clark, J. L., Marti, X. L., Walker, J. E., SHOPTAW, S. J., & Coffin, P. O. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112769 · Cited by 6
Kangiser, M. M., Dwoskin, L. P., Zheng, G., Crooks, P. A., & Stairs, D. J. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000340 · Cited by 6
Wesley, M. J., Westgate, P. M., Stoops, W. W., Kelly, T. H., Hays, L. R., & Lile, J. A. (2018) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000180 · Cited by 6
Liu, Y., Bao, Y., Sun, H., Beveridge, T. J. R., Li, S., Di, X.-L., Yang, F., & Lü, L. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181e78a2b · Cited by 6
Human Laboratory Models of Cannabis Use Disorder
Arout, C. A., Herrmann, E. S., & Haney, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_9 · Cited by 6
Self-citationCocaine self-administration attenuates brain glucose metabolism and functional connectivity in rats
Rowan, C., Hanna, C., Sajjad, M., Yao, R., Sharafshah, A., Lewandrowski, K., Blum, K., Pinhasov, A., & Thanos, P. K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324522 · Cited by 5
Simmons, S. J., Barker, D. J., & West, M. O. (2018) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-809600-0.00037-8 · Cited by 5
Stangl, B. L., Byrd, N. D., Soundararajan, S., Plawecki, M. H., O’Connor, S., & Ramchandani, V. A. (2022) · Journal of Visualized Experiments · doi:10.3791/63576 · Cited by 5
Metadata
- Authors
- Haney, M., & Spealman, R.
- Affiliations
- New York State Psychiatric Institute (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Haney, Margaret
- ORCID
- Haney, Margaret
- Venue
- Psychopharmacology
- Published
- 2008-02-19
- Volume
- 199
- Issue
- 3
- Pages
- 403-419
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC2731701
- OpenAlex
- W1965528317
- Cited by
- 270
- References
- 187
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 7 · 2023: 5 · 2022: 12 · 2021: 12 · 2020: 16 · 2019: 18 · 2018: 13 · 2017: 17 · 2016: 23 · 2015: 21 · 2014: 15 · 2013: 14 · 2012: 16
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (DA-09236, DA11054, R01DA019239, DA11928, DA 19239, R01DA017700, R01DA011054, P50DA009236, DA17700, 09236, R01DA011928)
- National Center for Research Resources (RR00 168, K26RR000168, P51RR000168)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- self-administration, translational research, heroin addiction, cocaine dependence, opioid antagonists, opioid agonists, partial agonists, modafinil, ecopipam, aripiprazole, abuse liability, predictive validity, non-human primates
- MeSH terms
- Animals, Disease Models, Animal, Heroin Dependence, Humans, Primates, Rodentia, Self Administration, Substance-Related Disorders, Cocaine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review